SM
Swathi Medoju
About Swathi Medoju
Data last updated:
Swathi Medoju is a Designated Partner at Parivaar Pranayama Llp (since 2025) and Director at Alphine Pharmaceuticals Private Limited (since 2014). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Parivaar Pranayama Llp ACR-8395 | Designated Partner | 28 Oct 2025 | 2025 | Active | |
| Alphine Pharmaceuticals Private Limited U33120TG2014PTC095228 | Director | 11 Aug 2014 | 2014 | Active |
Board colleagues of Swathi Medoju
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gaddala Sainath | 11329370 | Parivaar Pranayama Llp | Designated Partner |
| Sri Harsha Teja Chaganty | 11280330 | Parivaar Pranayama Llp | Designated Partner |
| Bhaskara Chary Bejjenki | 06923802 | Alphine Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Swathi Medoju
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swathi Medoju
Swathi Medoju currently holds 2 directorships: Parivaar Pranayama Llp (Designated Partner, since 28 Oct 2025); Alphine Pharmaceuticals Private Limited (Director, since 11 Aug 2014).
Swathi Medoju was first appointed on 11 Aug 2014 as Director at Alphine Pharmaceuticals Private Limited. The most recent appointment on record is 28 Oct 2025 at Parivaar Pranayama Llp.
The current boards of Swathi Medoju's companies include Gaddala Sainath (Parivaar Pranayama Llp), Sri Harsha Teja Chaganty (Parivaar Pranayama Llp), Bhaskara Chary Bejjenki (Alphine Pharmaceuticals Private Limited).